Page 8 - Randomised Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

06 Jun 2021 / 07:14 H. KUALA LUMPUR: The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals. Health director-general Tan Sri Dr Noor Hisham Abdullah (pix) said Ivermectin is a Food and Drug Administration (FDA) approved antiparasitic drug widely used for treating several neglected tropical diseases, including onchocerciasis, strongyloidiasis and helminthiases, however, the evidence is inconclusive to recommend routine use of Ivermectin for Covi...

KUALA LUMPUR, June 5 — The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals. Health director-general Tan Sri Dr Noor Hisham Abdullah said...

KUALA LUMPUR (Bernama): The Health Ministry and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 of the ministry's hospitals.

Why India finally scrapped plasma as Covid treatment, 7 months after ICMR said it doesn’t work Abantika Ghosh © Provided by The Print New Delhi: It was exactly seven months ago that Dr Balram Bhargava, director general of the Indian Council of Medical Research (ICMR) first announced that India is planning to remove plasma therapy as a Covid-19 treatment option. An ICMR study found that infusing blood plasma from a recovered patient showed no significant benefits on a patient’s eventual outcome. The decision was finally announced late Monday night, when infusion of conval...

India made two crucial changes to its Covid treatment protocol, both were prompted by the research done in the UK and published in the reputed medical journal 'The Lancet'.